Viewing Study NCT05118360

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-05-20 @ 10:58 AM
Study NCT ID: NCT05118360
Status: WITHDRAWN
Last Update Posted: 2024-09-27
First Post: 2021-11-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH
Sponsor: Gannex Pharma Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Nonalcoholic Steatohepatitis (NASH) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NAFLD View
None Phase 2 View
None Thyroid hormone receptor agonist View
None NASH View
None ASC41 View